Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.
Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model.
Natalizumab therapy for multiple sclerosis.
Secondary progressive multiple sclerosis: a shared therapeutic decision.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Integrative therapies for multiple sclerosis.
Culturing microglia from the neonatal and adult central nervous system.
Pages
« first
‹ previous
…
398
399
400
401
402
403
404
405
406
…
next ›
last »